Deferred Tax Assets, Valuation Allowance in USD of agilon health, inc. from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
agilon health, inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2024.
  • agilon health, inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $429M, a 17.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

agilon health, inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $429M +$62.8M +17.2% Dec 31, 2024 10-K 2025-02-25
Q4 2023 $366M +$51.8M +16.5% Dec 31, 2023 10-K 2025-02-25
Q4 2022 $314M +$53.6M +20.6% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $261M +$134M +105% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $127M Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.